Choose an administration site on your stomach (at least two inches away from your belly button), thigh, or upper arm
In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
10.1093/hmg/ddl066 363 ManczakM.CalkinsM
Its caused by a buildup of scar tissue and fat deposits
Injection Procedure Site selection: Abdomen (2+ inches from the navel), outer thigh or back of the upper arm rotate sites systematically
Private by default GLPzy is designed to work without a mandatory in-app account, and the local-first privacy page explains records, backups, exports, and boundaries in plain language